Sergio Escamilla
Alicante, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Meprin-β levels are increased in the brain and the cerebrospinal fluid of Alzheimer's disease patients.
Journal: Alzheimer's research & therapy
Published: April 07, 2026
GluN2A-mediated currents and calcium signal in human iPSC-derived neurons.
Journal: Scientific reports
Published: September 29, 2025
Development and Validation of an ICP-MS/MS Method for the Multielemental Analysis of Cerebrospinal Fluid, Examination of Alzheimer's Disease Samples.
Journal: Journal of neurochemistry
Published: June 04, 2025
Alterations of NMDAR Subunits in the Cerebrospinal Fluid Across Neurodegenerative and Immunological Disorders.
Journal: Journal of neurochemistry
Published: December 22, 2024
NMDARs in Alzheimer's Disease: Between Synaptic and Extrasynaptic Membranes.
Journal: International journal of molecular sciences
Published: September 02, 2024
Thyroid Hormone and Alzheimer Disease: Bridging Epidemiology to Mechanism.
Journal: Endocrinology
Published: June 05, 2024
Synaptic and extrasynaptic distribution of NMDA receptors in the cortex of Alzheimer's disease patients.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: March 18, 2024
No evidence for cognitive decline or neurodegeneration in strain-matched Grin3a knockout mice.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: May 03, 2023
The apolipoprotein receptor LRP3 compromises APP levels.
Journal: Alzheimer's research & therapy
Published: February 10, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026